Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > insider details posted - Mandel, Hachey and RDW.

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Feb 06, 2024 12:30pm

385 Views

Post# 35865529

insider details posted - Mandel, Hachey and RDW.

Filed 2024-02-06 09:58 Tx date 2024-02-05	$TLT Theralase Technologies Inc.	Mandel, Arkady 5 - Senior Officer of Issuer Direct Ownership	Warrants 53 - Grant of warrants	$34,722 +138,889 vol $0.25 each	238,889
Filed 2024-02-06 09:57 Tx date 2024-02-05	$TLT Theralase Technologies Inc.	Mandel, Arkady 5 - Senior Officer of Issuer Direct Ownership	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$25,000 +138,889 vol $0.18 each	298,889
Filed 2024-02-06 09:51 Tx date 2024-02-05	$TLT Theralase Technologies Inc.	Hachey, Kristina Maria 5 - Senior Officer of Issuer Direct Ownership	Warrants 53 - Grant of warrants	$69,444 +277,778 vol $0.25 each	2,230,635
Filed 2024-02-06 09:50 Tx date 2024-02-05	$TLT Theralase Technologies Inc.	Hachey, Kristina Maria 5 - Senior Officer of Issuer Direct Ownership	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$50,000 +277,778 vol $0.18 each	3,034,045
Filed 2024-02-06 09:47 Tx date 2024-02-05	$TLT Theralase Technologies Inc.	Dumoulin-White, Roger John 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Warrants 53 - Grant of warrants	$162,347 +649,389 vol $0.25 each	4,908,052